Royal Bank Of Canada Rezolute, Inc. Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.29 - $5.79 $421 - $1,065
184 New
184 $0
Q4 2023

Feb 14, 2024
BUY
$0.74 - $1.24 $218 - $365
295 Added 655.56%
340 $0
Q3 2023

Nov 14, 2023
SELL
$1.32 - $2.1 $289 - $459
-219 Reduced 82.95%
45 $0
Q2 2023

Aug 14, 2023
BUY
$1.75 - $2.33 $462 - $615
264 New
264 $0
Q3 2022

Nov 14, 2022
BUY
$2.19 - $3.49 $146 - $233
67 New
67 $0

Others Institutions Holding RZLT

# of Institutions
62
Shares Held
38.5M
Call Options Held
1.6K
Put Options Held
24.6K
View Full List

About Rezolute, Inc.

RZLT Quotes by TradingView
  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $171M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email